341 related articles for article (PubMed ID: 29675950)
1. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
Karafin MS; Westlake M; Hauser RG; Tormey CA; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Hendrickson JE;
Br J Haematol; 2018 Jun; 181(5):672-681. PubMed ID: 29675950
[TBL] [Abstract][Full Text] [Related]
2. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
Karafin MS; Tan S; Tormey CA; Spencer BR; Hauser RG; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Gottschall JL; Hendrickson JE
Transfusion; 2019 Jan; 59(1):217-225. PubMed ID: 30427537
[TBL] [Abstract][Full Text] [Related]
5. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
Moreira JĂșnior G; Bordin JO; Kuroda A; Kerbauy J
Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Ameen R; Al Shemmari S; Al-Bashir A
Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
10. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
[TBL] [Abstract][Full Text] [Related]
14. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization: lessons from sickle cell disease.
Treml A; King KE
Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
[No Abstract] [Full Text] [Related]
16. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
18. Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.
Chhetri R; Wee LYA; Sinha R; Kutyna MM; Pham A; Stathopoulos H; Nath L; Nath SV; Wickham N; Hughes T; Singhal D; Roxby DJ; Hiwase DK
Haematologica; 2019 Oct; 104(10):e451-e454. PubMed ID: 30819906
[No Abstract] [Full Text] [Related]
19. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
[TBL] [Abstract][Full Text] [Related]
20. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]